This page includes the latest FDA filings for Adamis Pharmaceuticals Corp. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
USA | NASDAQ | ADMP | DUNS 618661680 |
Device Company | Device | Date |
---|---|---|
Adamis Pharmaceuticals Corporation, Catalent Belgium S.A. | Prescription Medication | 2019-02-07 |
Adamis Pharmaceuticals Corporation | SYMJEPI | 2017-11-15 |
NCAGE Code | 6G5P4 | ADAMIS PHARMACEUTICALS CORPORATION |
CAGE Code | 6G5P4 | ADAMIS PHARMACEUTICALS CORPORATION |
SEC | 0000887247 | Adamis Pharmaceuticals Corp of DELAWARE |
SEC | 0001427933 | Adamis Pharmaceuticals CORP of DELAWARE |
SEC | 0001380239 | Adamis Pharmaceuticals Corp |